These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 37173520)
1. A Combined In-Vitro and GastroPlus® Modeling to Study the Effect of Intestinal Precipitation on Cinnarizine Plasma Profile in a Fasted State. Kesharwani SS; Ibrahim F AAPS PharmSciTech; 2023 May; 24(5):121. PubMed ID: 37173520 [TBL] [Abstract][Full Text] [Related]
2. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability. Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981 [TBL] [Abstract][Full Text] [Related]
3. In vivo evaluation of supersaturation/precipitation/re-dissolution behavior of cinnarizine, a lipophilic weak base, in the gastrointestinal tract: the key process of oral absorption. Tanaka Y; Kawakami A; Nanimatsu A; Horio M; Matsuoka J; Wada T; Kasaoka S; Yoshikawa H Eur J Pharm Sci; 2017 Jan; 96():464-471. PubMed ID: 27773836 [TBL] [Abstract][Full Text] [Related]
4. Integration of Precipitation Kinetics From an In Vitro, Multicompartment Transfer System and Mechanistic Oral Absorption Modeling for Pharmacokinetic Prediction of Weakly Basic Drugs. Patel S; Zhu W; Xia B; Sharma N; Hermans A; Ehrick JD; Kesisoglou F; Pennington J J Pharm Sci; 2019 Jan; 108(1):574-583. PubMed ID: 30395833 [TBL] [Abstract][Full Text] [Related]
5. Model-Based Analysis of Biopharmaceutic Experiments To Improve Mechanistic Oral Absorption Modeling: An Integrated in Vitro in Vivo Extrapolation Perspective Using Ketoconazole as a Model Drug. Pathak SM; Ruff A; Kostewicz ES; Patel N; Turner DB; Jamei M Mol Pharm; 2017 Dec; 14(12):4305-4320. PubMed ID: 28771009 [TBL] [Abstract][Full Text] [Related]
6. In Vitro, in Silico, and in Vivo Assessments of Intestinal Precipitation and Its Impact on Bioavailability of a BCS Class 2 Basic Compound. Kou D; Zhang C; Yiu H; Ng T; Lubach JW; Janson M; Mao C; Durk M; Chinn L; Winter H; Wigman L; Yehl P Mol Pharm; 2018 Apr; 15(4):1607-1617. PubMed ID: 29522347 [TBL] [Abstract][Full Text] [Related]
7. Precipitation in the small intestine may play a more important role in the in vivo performance of poorly soluble weak bases in the fasted state: case example nelfinavir. Shono Y; Jantratid E; Dressman JB Eur J Pharm Biopharm; 2011 Oct; 79(2):349-56. PubMed ID: 21527341 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal dissolution, supersaturation and precipitation of the weak base indinavir in healthy volunteers. Rubbens J; Brouwers J; Tack J; Augustijns P Eur J Pharm Biopharm; 2016 Dec; 109():122-129. PubMed ID: 27693678 [TBL] [Abstract][Full Text] [Related]
9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
10. Oral Absorption from Surfactant-Based Drug Formulations: The Impact of Molecularly Dissolved Drug on Bioavailability. Holzem FL; Parrott N; Petrig Schaffland J; Brandl M; Bauer-Brandl A; Stillhart C J Pharm Sci; 2024 Oct; 113(10):3054-3064. PubMed ID: 39059554 [TBL] [Abstract][Full Text] [Related]
11. Prediction of plasma profiles of a weakly basic drug after administration of omeprazole using PBPK modeling. Segregur D; Mann J; Moir A; Karlsson EM; Dressman J Eur J Pharm Sci; 2021 Mar; 158():105656. PubMed ID: 33253885 [TBL] [Abstract][Full Text] [Related]
12. Increasing the Robustness of Biopharmaceutical Precipitation Assays - Part II: Recommendations on the use of FaSSIF. Krollik K; Lehmann A; Wagner C; Kaidas J; Bülhoff J; Kubas H; Weitschies W J Pharm Sci; 2022 Jan; 111(1):155-163. PubMed ID: 34461113 [TBL] [Abstract][Full Text] [Related]
13. Effect of supersaturation on absorption of indomethacin and tadalafil in a single pass intestinal perfusion rat model, in the absence and presence of a precipitation inhibitor. Strindberg S; Plum J; Stie MB; Christiansen ML; Hagner Nielsen L; Rades T; Müllertz A Eur J Pharm Biopharm; 2020 Jun; 151():108-115. PubMed ID: 32298758 [TBL] [Abstract][Full Text] [Related]
14. In vitro-in vivo correlation of the effect of supersaturation on the intestinal absorption of BCS Class 2 drugs. Higashino H; Hasegawa T; Yamamoto M; Matsui R; Masaoka Y; Kataoka M; Sakuma S; Yamashita S Mol Pharm; 2014 Mar; 11(3):746-54. PubMed ID: 24460473 [TBL] [Abstract][Full Text] [Related]
15. The Use of Global Sensitivity Analysis to Assess the Oral Absorption of Weakly Basic Compounds: A Case Example of Dipyridamole. Kesharwani SS; Louit G; Ibrahim F Pharm Res; 2024 May; 41(5):877-890. PubMed ID: 38538971 [TBL] [Abstract][Full Text] [Related]
16. Role of physiological intestinal water in oral absorption. Sutton SC AAPS J; 2009 Jun; 11(2):277-85. PubMed ID: 19412669 [TBL] [Abstract][Full Text] [Related]
17. In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of Posaconazole. Hens B; Pathak SM; Mitra A; Patel N; Liu B; Patel S; Jamei M; Brouwers J; Augustijns P; Turner DB Mol Pharm; 2017 Dec; 14(12):4321-4333. PubMed ID: 28817288 [TBL] [Abstract][Full Text] [Related]
18. In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib. Tsume Y; Takeuchi S; Matsui K; Amidon GE; Amidon GL Eur J Pharm Sci; 2015 Aug; 76():203-12. PubMed ID: 25978875 [TBL] [Abstract][Full Text] [Related]
19. Application of a Dynamic Fluid and pH Model to Simulate Intraluminal and Systemic Concentrations of a Weak Base in GastroPlus Hens B; Bolger MB J Pharm Sci; 2019 Jan; 108(1):305-315. PubMed ID: 30395828 [TBL] [Abstract][Full Text] [Related]
20. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. Gu CH; Rao D; Gandhi RB; Hilden J; Raghavan K J Pharm Sci; 2005 Jan; 94(1):199-208. PubMed ID: 15761943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]